727 Use of PI3K/mTOR/Akt Inhibitors as Skin Protectors to Spare Skin From Glucocorticoid-Induced Atrophy

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.803
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Deletion of the Glucocorticoid Receptor Chaperone FKBP51 Prevents Glucocorticoid-Induced Skin Atrophy

Oncotarget
Oncology
2018English

Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Reply: Glucocorticoid Use and Skin Cancers

British Journal of Cancer
Cancer ResearchOncology
2003English

Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

Dexmedetomidine Suppresses Sevoflurane Anesthesia-Induced Neuroinflammation Through Activation of the PI3K/Akt/mTOR Pathway

BMC Anesthesiology
AnesthesiologyPain Medicine
2019English

Periostin Facilitates Skin Sclerosis via PI3K/Akt Dependent Mechanism in a Mouse Model of Scleroderma

PLoS ONE
Multidisciplinary
2012English

A Novel Animal Model of Pruritus Induced by Successive Application of Glucocorticoid to Mouse Skin

Journal of Toxicological Sciences
MedicineToxicology
2011English

Emodin-Induced Autophagy Against Cell Apoptosis Through the PI3K/AKT/mTOR Pathway in Human Hepatocytes

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy